4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-046897
CFO, EVP & Treasurer sold 5,632 shares at $42.35 ($238,515)
- CFO, EVP & Treasurer acquired 5,632 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-04-17 | Option exercise 10b5-1 | +5,632 | $13.35 | $75,187 | 110,780 | D |
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-04-17 | Sale 10b5-1 | −5,632 | $42.35 | $238,515 | 105,148 | D |
| Derivatives | |||||||
| PETERS WILLIAM J CFO, EVP & Treasurer | 2023-04-17 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,632 | 28,990 | D | ||
| Open-market sales · 5,632 sh · avg $42.35 · $238,515 | |||||||
Loading xslF345X04/tm2311755-6_4seq1.xml…